Weight Wellness Program News Today

LPCN 2401 treatment resulted in statistically significant body composition improvement in menIncreased lean mass (LM) by 4.4% and decreased fat mass (FM) by 6.7%Reduced android fat (AF) by 4.1% and

There is a wide variation in how much weight people lose on GLP-1 medications.

Weight loss shots have skyrocketed in popularity over the last year. We're looking beyond the trends to uncover the truth about these meds and their promises.

Weight loss shots have skyrocketed in popularity over the last year. We're looking beyond the trends to uncover the truth about these meds and their promises.

Despite the rapid emergence of glucagonlike peptide-1 agonists for treating obesity, bariatric surgery may still be a better choice for some individuals, two experts say.

Ozempic, Wegovy, and Saxenda are under investigation by the European Medicines Agency for possibly causing consumers to self-harm or experience suicidal thoughts. Clinical trials of the drug did not see this to be a large risk factor, but experts note a changing population of those taking the drugs may have shifted risk levels.

Endocrinologists are throwing cold water on TikToks claims that the supplement berberine produces the same amount of weight loss seen with new medications like semaglutide or tirzepatide.

Find out the pros and cons of using BMI, body fat percentage calculations and more to determine if a person is overweight, obese or at-risk of obesity.

MONDAY, June 5, 2023 (HealthDay News) -- When people regained weight after obesity surgery, it wasn’t entirely clear what to do next. Now, it appears the weight-loss medications Wegovy and

BMI is the go-to obesity metric, but there is increasing acknowledgment that its an imperfect measure and can differ with ethnicity, sex, and body frame; hence, the growing chorus for alternatives.